ArticleGastroenterology research and practice2026
Relationship Between Blood Urea Nitrogen to Albumin Ratio and Risks of Mortality and Delirium in Pancreatitis Patients: A Retrospective Analysis of the MIMIC-IV Database.
Article in Gastroenterology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: This study is aimed at evaluating the predictive value of the blood urea nitrogen-to-albumin ratio (BAR) for both mortality and delirium risk in patients with pancreatitis. Pancreatitis carries a substantial mortality risk and significant long-term sequelae, with delirium being a severe neurological complication, underscoring the clinical need for effective prognostic markers. Methods: A retrospective cohort study was performed using the MIMIC-IV v3.0 database. A total of 1748 ICU patients meeting diagnostic criteria for pancreatitis (ICD-9/10 codes: 577.0, 577.1, K85) with documented baseline blood urea nitrogen (BUN) and albumin levels were included. BAR was calculated (BUN[mg/dL]/Albumin[g/dL]) and patients were stratified into quartiles (Q1: BAR < 3.0; Q2: BAR 3.0-5.0; Q3: BAR 5.0-9.2; Q4: BAR ≥ 9.2). The primary endpoints were all-cause mortality and delirium occurrence (identified using ICD-9 codes 293.0, 293.1, and ICD-10 codes F05, F05.9). Multivariable Cox proportional hazards regression (mortality) and logistic regression (delirium) were employed, adjusting for demographics, illness severity scores (GCS, SAPS II, OASIS, and Charlson Comorbidity Index), and comorbidities. Restricted cubic splines (RCS) were used to explore nonlinear associations. Results: Higher BAR levels significantly correlated with greater disease severity: compared with Q1, Q4 exhibited a higher Charlson Comorbidity Index and mortality rate. BAR was an independent predictor of delirium; each 1-unit increase in BAR was associated with a 2.7% increased risk of delirium (adjusted OR = 1.027, 95% CI: 1.009-1.044), and patients in Q4 had a significantly higher risk compared with those in Q1 (adjusted OR = 1.882, 95% CI: 1.157-3.108). After multivariable adjustment, BAR was not significantly independently associated with mortality (Q4 adjusted HR = 1.022, Conclusion: BAR independently predicts delirium risk and reflects disease severity in pancreatitis patients, but does not demonstrate significant independent predictive value for mortality after accounting for confounders. The identified threshold (BAR > 9.0) supports the utility of BAR as a supplementary biomarker for delirium risk stratification in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.